“Building on a 2015 study, researchers at the Yale schools of Medicine and Public Health have demonstrated the cost-effectiveness of buprenorphine as an emergency department treatment for individuals with opioid use disorder.
The study analyzed the cost-effectiveness of three treatments for individuals screening positive for opioid addiction: referral alone, brief counseling intervention with facilitated referral and ED-initiated buprenorphine. ED-initiated buprenorphine was the most cost-effective with an average cost of $1,752, compared with $1,805 for brief intervention and $1,977 for referral only. Led by Yale School of Public Health professor Susan Busch and medical school professor Gail D’Onofrio, the study was published in the journal Addiction in August 2017.”
Source: YaleDailyNews.com – September 5, 2017